Agonist binding evokes extensive conformational changes in the extracellular domain of the ATP-gated human P2X1 receptor ion channel by Roberts, J. A. et al.
Agonist binding evokes extensive conformational
changes in the extracellular domain of the ATP-gated
human P2X1 receptor ion channel
Jonathan A. Robertsa, Rebecca C. Allsoppa, Sam El Ajouza, Catherine Viala, Ralf Schmidb, Mark T. Youngc,1,
and Richard J. Evansa,1
aDepartment of Cell Physiology and Pharmacology and bDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom;
and cSchool of Biosciences, Cardiff University, Cardiff CF10 3AX, United Kingdom
Edited by Michael J. Welsh, Howard Hughes Medical Institute, Iowa City, IA, and approved February 9, 2012 (received for review February 1, 2012)
P2X receptors for ATP have a wide range of physiological roles and
comprise a structurally distinct family of ligand-gated trimeric ion
channels. The crystal structure of a P2X4 receptor, in combination
with mutagenesis studies, has provided a model of the intersubunit
ATP-binding sites and identiﬁed an extracellular lateral portal,
adjacent to the membrane, that funnels ions to the channel pore.
However, little is known about the extent of ATP-induced confor-
mational changes in the extracellular domain of the receptor. To
address this issue, we have used MTSEA-biotinylation (N-Biotinoy-
laminoethyl methanethiosulfonate) to show ATP-sensitive accessi-
bility of cysteine mutants at the human P2X1 receptor. Mapping
these data to a P2X1 receptor homologymodel identiﬁes signiﬁcant
conformational rearrangement. Electron microscopy of puriﬁed
P2X1 receptors showed marked changes in structure on ATP bind-
ing, and introducing disulphide bonds between adjacent subunits to
restrict intersubunit movements inhibited channel function. These
results are consistent with agonist-induced rotation of the propel-
ler-head domainof the receptor, sliding of adjacent subunits leading
to restricted access to the upper vestibule, movement in the ion
conducting lateral portals, and gating of the channel pore.
purinergic receptor | cysteine-scanning
ATP functions not only as an energy carrier within cells butalso acts extracellularly at P2 receptors (G protein-coupled
P2Y receptors and ligand-gated P2X receptor cation channels)
(1) to mediate signaling between cells. A role for purinergic
signaling was ﬁrst suggested in the 1970s (2) and it is now known
that one or more P2X receptor subtypes are expressed on vir-
tually every cell type in the body (3, 4). Given the almost ubiq-
uitous expression of the receptors, it is not surprising that they
have been shown to have widespread physiological roles, ranging
from taste sensation to bone formation (3, 5). In addition, P2X
receptors contribute to pathophysiological states, including throm-
boembolism (6) and pain (7), highlighting the considerable ther-
apeutic potential of P2X receptor-selective drugs (4).
Genes encoding seven mammalian P2X receptors have been
identiﬁed (P2X1 to -7). Functional receptors form from the
homo- or heterotrimeric assembly of subunits with intracellular
amino and carboxyl termini, two transmembrane segments, and
a large extracellular ligand-binding loop (8). This topology and
stoichiometry is different from that of the cys loop and glutamate
gated ion channels (9). The crystalisation of a zebraﬁsh P2X4
receptor in an ATP-free, closed, resting state (10) provided
a major advance in understanding the molecular basis of receptor
function. The individual subunits have been likened to the shape
of a dolphin (Fig. S1), with the transmembrane domains corre-
sponding to the ﬂuke and the extracellular region to the body,
with a cysteine-rich head domain, ﬂippers, and a dorsal ﬁn. The
three subunits are entwined in a right-handed twist surrounding
the upper, central, and extracellular vestibules (Figs. 1A and 2B).
The 3D structure supports many previous mutagenesis-based
predictions (for reviews, see refs. 11–13) and was a catalyst for
recent studies that have further extended the understanding of
the molecular basis of the ligand-binding site (14, 15) and ionic
permeation through the extracellular vestibule (lateral portal) of
the extracellular domain to the transmembrane pore (15–17).
ATP binding induces a conformational change that leads to gating
of the ion-channel pore. However, the zebraﬁsh P2X4 receptor
structure provides only a snapshot of the receptor in an agonist-
free closed state. A major unanswered question is the nature and
extent of agonist-induced conformational changes on receptor
activation in this distinct family of ligand-gated ion channels.
In this study we have used cysteine mutagenesis, N-Bio-
tinoylaminoethyl methanethiosulfonate (MTSEA-biotinylation),
and electron microscopy to map the extent of ATP-induced struc-
tural rearrangement in the human P2X1 receptor. Introduction of
disulphide bonds between the P2X1 receptor subunits showed that
subunit rearrangement is essential for receptor activation. These
studies provide an insight into agonist-induced changes in the ex-
tracellular ligand binding domain of a P2X receptor and suggest
that receptor activation involves movement of the subunits, with
rotation of the cysteine-rich head, restricted access to the upper
vestibule, and gating of the ion-conducting pore.
Results
ATP-Sensitive Accessibility of Cysteine Mutant P2X1 Receptors. The
predicted ATP binding site forms a groove/open jaw between
adjacent subunits with ATP coordinated by N290, F291, R292,
and K309 of the left-hand subunit and K68 and K70 of the right-
hand subunit (Fig. S1). It has been suggested that agonist binding
induces movement between the subunits, closing the agonist-
binding pocket (10). Such rearrangement is also likely to result in
changes in access to the vestibules within the extracellular domain
bordered/enclosed by the subunits. To test for a conformational
change, we have used MTSEA-biotinylation to determine the
accessibility of a series of individual cysteine mutants (E52C to
G96C) in the extracellular domain of the human P2X1 receptor
(and whether this is ATP-sensitive). These mutants, which are all
functional and expressed at the cell surface (15), stretch from the
ﬁrst transmembrane segment to the receptor apex, and incor-
porate residues lining the upper, central, and extracellular/lateral
vestibules and part of the ligand binding site (Fig. 1A).
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MTSEA-biotin binds to exposed cysteine residues and pro-
vides a biochemical measure of their accessibility. In control
experiments on WT human P2X1 receptors expressed in Xen-
opus oocytes, MTSEA-biotinylation was not detected either in
the absence (15 U/mL apyrase to break down any endogenous
ATP) or presence of ATP (1 mM) (Fig. 1 B–D). This ﬁnding is
consistent with the 10 conserved native cysteine residues in the
extracellular loop forming ﬁve disulphide bonds (10). MTSEA-
biotinylation was also below detectable levels for alternate
mutants in the β-strand L61-K70, as well as for mutants S58C
and Q83C (Fig. 1 C and D, and Fig. S2). For the mutants E52C-
T57C, K68C, K70C, A73C, Q76C-G81C, V84C, and D86C,
MTSEA-biotinylation was detected at similar levels in both the
absence and presence of ATP. For the remainder of the mutants,
S59C, G60C, I62C, S64C, S66C, G71C, L72C, V74C, T75C,
P82C, W85C, and V87C-G96C MTSEA-biotinylation was
detected in the absence and reduced in the presence of ATP
(Fig. 1 C and D). These decreases demonstrate agonist-induced
changes in accessibility.
Mapping ATP-Sensitive Changes in Accessibility of Cysteine Mutants
Reveals Extensive Conformational Rearrangement. To gain a mech-
anistic insight into the patterns of biotinylation, the results for
E52C-G96C, as well as data from previous studies [E181C-
V200C (18) and S286C-I329C (19)], have been mapped onto
a P2X1 receptor homology model (15) (Fig. 2). Inaccessible
residues are predominantly buried within the receptor (Fig. S3).
Cysteine mutants that were biotinylated can be divided into three
groups: (i) those on the receptor surface around the mouth of
the lateral portal, and at the apex of the receptor that are ac-
cessible in the presence/absence of ATP; (ii) residues around the
agonist binding site, where MTSEA-biotinylation was generally
reduced by ATP consistent with an allosteric reduction in ac-
cessibility; and (iii) residues that line, or are at the interface
between, subunits that form the upper and central vestibules,
where ATP reduced MTSEA-biotinylation. These results dem-
onstrate that ATP binding leads to reduced access to the upper
and central vestibules and suggests that ATP binding evokes
signiﬁcant conformational movement in the extracellular domain
of the receptor.
The P2X1 receptor shows marked desensitization during the
continued presence of agonist (time to 50% desensitization: ∼1 s)
and the changes in biotinylation in response to ATP application
may reﬂect a distinct desensitized conformation of the receptor.
We have shown recently that desensitization is abolished upon
replacement of amino acids 16–49 in P2X1 with those from the
human P2X2 receptor (chimera P2X1-2NβTM1, corresponding
to the second half of the intracellular amino terminus and the
ﬁrst transmembrane domain) (20). We therefore generated
cysteine mutants on the nondesensitizing P2X1-2NβTM1 re-
ceptor background corresponding to the base/mouth of the lat-
eral portal (S56C), apex of the receptor (L80C), and residues in
the upper and central vestibules (Q95C and S64C). In these
studies, ATP was applied for 1 min before a 5-min coincubation
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Fig. 1. MTSEA-biotinylation reveals the extent of ATP-induced changes in accessibility of the cysteine mutants E52C to G96C. (A) Schematic representation of
cysteine-scanned region. Mutated residues are shown as spheres with rainbow colors (red, E52-S59; orange, G60-S64; yellow, V65-V67; green, K68-K70; blue,
G71-T75; indigo, Q76-L80; and violet, G81-G96) for the P2X1 subunit in the front of the picture. The overall structure of this subunit is shown in black cartoon
representation and the two P2X1 subunits in the background are shown in surface and grid representation, respectively. (B) To determine the surface ac-
cessibility of cysteine residues, oocytes were incubated with MTSEA-biotin, biotinylated proteins isolated, separated by SDS/PAGE, and blotted with anti-P2X1
receptor antibody. Blots show MTSEA biotinylation was not detected from WT P2X1 receptors either when pretreated with apyrase (to break down en-
dogenous nucleotides) or ATP (to activate the receptor). Total levels of the WT P2X1 receptor are shown for the oocytes before isolation of biotinylated
proteins. (C) Representative blots of MTSEA-biotinylation of WT and P2X1 receptor mutants. Blots are representative of those from three to eight separate
batches of oocytes. Controls for the expression of total P2X1 receptor protein for mutants where biotinylation was below the limit of detection are shown in
Fig. S2. (D) Densitometic analysis using ImageJ calculated any change in MTSEA biotin accessibility at each point mutation following receptor activation with
ATP. Inaccessibility of particular mutants to MTSEA biotin is indicated by Ø. Conserved residues highlighted in black. Statistical analysis was performed by one-
way ANOVA followed by Bonferroni’s post test (*P < 0.05, **P < 0.01, ***P < 0.001).
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with ATP and MTSEA-biotin; currents evoked by 6-min appli-
cation of ATP at either the P2X1-NβTM1 receptor or cysteine
mutants on this background showed <10% desensitization (Fig.
S4). Biotinylation data from the P2X1-2NβTM1 receptor and
mutants in the presence of ATP are therefore likely to corre-
spond to an agonist-bound open form of the receptor.
Comparison of data for the cysteine mutants on the P2X1 and
P2X1-NβTM1 backgrounds allowed us to test whether the re-
duction in access to the upper and central vestibules at P2X1
receptor mutants corresponded to channel opening or a sub-
sequent desensitized state. The pattern of MTSEA-biotinyla-
tion for the P2X1-2NβTM1 background (not detected), P2X1-
2NβTM1 mutants S56C, L80C (detected but unaffected by ATP),
and Q95C (biotinylation reduced by ATP) was the same as for the
WT and corresponding cysteine mutants at the P2X1 receptor
(Fig. S4). In contrast, ATP application had no signiﬁcant effect on
the level of MTSEA-biotin access to the central vestibule (residue
S64C) at the nondesensitizing P2X1-2NβTM1 channel, but was
signiﬁcantly reduced in the desensitized P2X1 receptor back-
ground (Fig. S4). These results suggest that (i) ATP binding and
channel opening leads to reduced access to the upper vestibule,
and (ii) access to the central vestibule is reduced for the
desensitized receptor.
Electron Microscopy of P2X1 Receptors Demonstrates ATP-Induced
Rotation of the Cysteine-Rich Head and Visualization of Lateral
Portals. To gain a structural insight into ATP-sensitive confor-
mational changes, we used transmission electron microscopy
(TEM) to image negatively stained single puriﬁed P2X1 recep-
tors either in the absence or presence of ATP (Fig. 3 and Fig.
S5). Brieﬂy, HEK293 cells stably expressing human P2X1
receptors with a C-terminal FLAGHis6 tag were lysed, the re-
ceptor was solubilized in 1% n-Octyl glucoside, isolated with an
anti-FLAG M2 afﬁnity agarose gel/column, and purity was
conﬁrmed by mass spectrometry. Samples were adsorbed on to
carbon-coated TEM grids in either the presence or absence of
1 mM ATP (1 min), and single protein particles were imaged as
detailed in SI Methods. The overall dimensions of the native
structure (∼7 × 10 nm; 290 nm3) were consistent with those from
human P2X4 (21) and zebraﬁsh P2X4.1 (10) receptors, and the
extracellular domain “propeller” [also observed in the low-res-
olution human P2X4 (21) structure] that most likely corresponds
to the cysteine-rich head region of the protein was clearly visible
(Fig. 3A). Because of the use of negative stain and presence of
a detergent micelle, which stabilizes the transmembrane domains
in solution, it was not possible to gain any structural information
concerning the transmembrane domains (21).
In the presence of 1 mM ATP (Fig. 3B), the propeller-shaped
domain at the top of the structure was reduced in size, implying
an inward movement of the head region upon ATP binding. In
addition, we observed the appearance of an indent in the surface
of the structure that could potentially represent the lateral portal
pathway above the transmembrane domains. The differences be-
tween the two structures are most clearly observed in the com-
bined ﬁt displayed in Fig. 3B. We did not observe the opening of
a central pore in the extracellular domain, consistent with the
lateral pores being the sites of ion entry (15–17). These images
provide structural insight into agonist-induced conformational
changes at a P2X receptor.
Introduced Disulphide Bonds Between P2X1 Receptor Subunits Inhibit
Channel Activation. The MTSEA-biotinylation and TEM studies
suggested marked ATP-induced conformational changes consis-
tent with movement at the subunit interfaces and rotation of the
cysteine-rich head region. We have therefore used the P2X1 re-
ceptor homology model (15) to predict pairs of cysteine mutants
that could form disulphide bonds between subunits (Fig. 4A). The
ﬁrst set of mutants was designed to cross-link two subunits via the
core β-sheets of the body region. The β-sheets comprise strands
L61-K70, T186-F195, K199-R203 from one subunit and strands
G251-D262, I271-G278 (this strand leads to the “right ﬂipper”),
and K309-A323 from the adjacent subunit. Disulphide formation
would “lock” these sheets relative to each other. A second set of
pairs of cysteine mutants attempted to tag the cysteine-rich head
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Fig. 2. Mapping ATP sensitivity of cysteine mutant accessibility indicates
conformational change and restricted access to the upper and central ves-
tibules. (A) Homology model of the hP2X1 receptor; surface representation
shows the three subunits in white, light blue, and light pink. Cysteine
mutants that were accessible (as assessed by MTSEA-biotinylation) in the
absence or presence of ATP are shown in black and are on the cell surface at
the apex of the receptor and surrounding the entrance to the extracellular
vestibule/lateral portal (orange circle). Cysteine mutants that were reactive
with MTSEA-biotin, and this was reduced following binding ATP, are shown
in red. These residues broadly correspond to those around the ATP binding
site (black elipse). (B) Many of the cysteine mutants that were accessible are
not on the cell surface but present within the receptor (shown in red and
blue spheres for adjacent subunits) lining the upper and central vestibules
(wheat-colored mesh shows a rendering of the open space within the re-
ceptor). MTSEA-biotinylation at these mutants was reduced following ATP
binding and indicates reduced accessibility on channel activation.
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Fig. 3. Electron microscopy of P2X1 receptors shows ATP induced twisting
of the subunits. TEM of negatively stained single puriﬁed P2X1 receptor
protein particles [top view (Left) and side view (Right)] the absence (A) and
presence (B) of ATP. The differences between the two structures are shown
in B, with the structure in the absence of ATP shown as a mesh represen-
tation. (Scale bar, 5 nm.)
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domain to the adjacent subunit. Treatment with the reducing
agent DTT (10 mM) had no effect on ATP-evoked responses at
WT P2X1 receptors (Fig. 4B). DTT also had no effect at several
double-cysteine mutants (e.g., 60C-322C) and suggests that the
introduced cysteine residues are not in the correct orientation to
form a disulphide bond. In contrast, DTT potentiated ATP-
evoked currents at the double-cysteine mutants at the base (60C/
320C, 62C/320C, 196C/320, 196C/322C, and 197C/322C) of the
β-sheets of the body region, between the top of the central β-sheet
region and the “right ﬂipper” (190C-284C), and between the
cysteine-rich head region and the adjacent subunit (138C-181C).
DTT had no effect on the time course of responses, and no po-
tentiating effect on the constituent single cysteine mutants (Fig.
S6). These results are consistent with the introduced cysteine
residues forming disulphide bonds between the adjacent subunits
that constrained channel function, and suggest that conforma-
tional changes throughout the extracellular domain of the re-
ceptor are required for normal channel function.
Discussion
The determination of the crystal structure of the zebraﬁsh P2X4
receptor represented a major advance in our understanding of
the molecular properties of P2X receptors (10), but because the
structure was solved in the absence of ligand, little is known
about the conformational changes induced by ATP binding. In
this study we demonstrate that ATP binding results in extensive
movement between the three receptor subunits.
The crystal structure of zebraﬁsh P2X4 represents an agonist-
free closed conformation, and shows a series of three vestibules
(formed by the entwined subunits) that pass through the center
of the extracellular domain of the receptor. In the structure, the
dimensions of the constrictions to the upper vestibule are too
narrow for hydrated ions to pass (10). Accordingly, in our P2X1
receptor homology model based on the P2X4 structure, both the
upper and central vestibules are predicted to be too narrow for
MTSEA-biotin to gain access. However, in our biochemical
studies we show extensive MTSEA-biotinylation of cysteine
mutants lining the upper and central vestibules, as well as the
extracellular vestibule/lateral portal. This ﬁnding suggests that in
the absence of agonist, the P2X1 receptor can also, at least
temporarily, adopt a more open conformation, giving access to
the upper and central vestibules of the extracellular domain.
MTSEA-biotinylation of cysteine mutants in the upper vesti-
bule of both the rapidly desensitizing P2X1 and nondesensitizing
P2X1-2NβTM1 receptor was reduced by ATP. This result shows
that agonist binding and channel opening results in a conforma-
tional change, restricting access to the upper vestibule, and
supports recent studies showing that the upper vestibule does not
contribute to ionic permeation (15–17). The head region and
right ﬂipper (the loop incorporating the N-linked glycosylation
site Asn184) of one subunit border the outer reaches of the left-
hand side of the ATP-binding pocket, and have been proposed to
move relative to the adjacent subunit to close the agonist binding
site (10). The DTT sensitivity of double-cysteine mutants be-
tween the head, as well as the right ﬂipper, and the adjacent
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Fig. 4. Introduced disulphide bonds restrict intersubunit movement and
inhibit P2X receptor currents. (A) Homology model of the hP2X1 receptor,
cartoon (gray, light blue) and mesh (light pink) representation of three
subunits. Double-cysteine mutants 320C-62C, 320C-196C, 190C-284C, and
138-181 that were sensitive to the reducing agent DTT are shown as spheres
(blue and red from two separate subunits). (B) DTT (10 mM) had no effect on
currents at WT P2X1 receptors evoked by a maximal concentration of ATP.
(C) Currents at the 62C-320C mutant were reduced compared with WT and
potentiated by DTT treatment. (D) Summary of results. WT and mutant P2X1
receptors were expressed in Xenopus oocytes and ATP-evoked currents
recorded with two-electrode voltage clamp. Data are expressed as fold-
change following DTT treatment. *P < 0.01, **P < 0.001.
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Fig. 5. Model of agonist induced conformational changes and channel
gating. (A) Homology model of the hP2X1 receptor shown as cartoon (gray,
light blue, light pink). The core β-strands of the extracellular domain are il-
lustrated in backbone surface representation (gray, blue, red). (B) One
complete subunit in light pink and the TM2 (light blue, mesh), the linker
region from TM2 to Lys309 with neighboring beta-strands (blue), and the
cysteine rich head region (blue surface) of a second subunit are shown.
Residues Lys68, Lys70, and Lys309 that coordinate the phosphate tail of ATP
in the agonist binding pocket are shown as red and blue spheres, re-
spectively, at one subunit interface, a docked ATP molecule is shown in
yellow. The β-sheets are shown as red and blue backbone surfaces and the
positions where introduced disulphide bonds inhibited channel function as
shown as keyhole symbols indicating locking of a receptor conformation.
Movement of the β-strand 309-320 (arrow 1) relative to the two β-strands 62-
70 and 186-195 (red) of the adjacent subunit leads to movement in the TM2
(arrow 2) leading to opening of the channel gate.
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subunit (138C/181C and 284C/190C, respectively) supports ag-
onist-induced movement of adjacent subunits and demonstrates
conformational changes are functionally important. It seems
unlikely that the conformational change would result in the
subunits moving away from each other, as this would open the
ATP-binding pocket and would not be expected to result in
a decrease in MTSEA-biotinylation of residues lining the upper
vestibule. The simplest explanation is that ATP binding leads to
a counter-clockwise rotation of the subunits, closing the ligand-
binding pocket and gating the channel. This ﬁnding is consistent
with ATP-induced changes in both MTSEA-biotinylation and
TEM images of the puriﬁed P2X1 receptor.
The predicted ATP-binding pocket is ∼40 Å from the trans-
membrane pore-forming domains and raises the question as to
what extent the movements “initiated” in the head and right
ﬂipper around the binding site are transmitted to the rest of the
receptor. Key residues for ATP binding are lysines K68, K70,
and K309 of adjacent subunits. These residues are part of the
phosphate-binding moiety at the entry of the ATP-binding pocket
and directly connected to the transmembrane segments via
β-strands. Each of these strands is in turn part of a β-sheet L61-
K70, T186-F195, K199-R203 and G251-D262, I271-G278, and
K309-A323, respectively (Fig. 5A). Within a single subunit these
two β-sheets are closely packed together. MTSEA-biotinylation
data for residues at the interface between the two sheets within
a subunit (L61, S63, V65, V67, L187, I189, N191, I193) demon-
strate that they remain inaccessible under both ATP-bound and
ATP-free conditions, giving no indication of a conformational
change occurring at this interface. However, cross-linking the two
β-sheets of adjacent subunits by introducing double-cysteine
mutations via strands I271-G278 and T186-F195 at the top to the
right ﬂipper (190C/284C, see above) or via strands K309-A323
and I62-K70 at the base (60C/320C, 62C/320C, 196C/320, 196C/
322C, and 197C/322C) inhibited channel function (Fig. 4). The
inhibition was reversed by the reducing agent DTT. The obser-
vation that intersubunit “locking” inhibited channel function
suggests that conformational change involving concerted move-
ment of the two cross-linked β-sheets relative to each other is
required for opening the channel (Fig. 5B, sites of disulphide
locking indicated by key-hole symbol). Combining this ﬁnding
with the fact that key residues of the ATP-binding site, K68 and
K309, are positioned at the upper end of each of the β-sheets but
the transmembrane helices forming the channel pore are con-
nected to the lower end, gives an intriguing model for signal
transmission. ATP binding triggers movement of the head region
and right ﬂipper, and in particular conformational changes of
residues K68, K70, and K309. In turn, this process leads to
movement of the two β-sheets of adjacent subunits relative to
each other. Both β-sheets are connected to transmembrane he-
lices so it seems plausible that this will affect the conformation of
the transmembrane region and result in channel opening. This
ﬁnding is also consistent with our previous studies, suggesting
that G60 movement was important for channel gating of the
P2X1 receptor (15) and studies on the P2X2 receptor that pro-
posed a salt bridge between adjacent subunits at the top of the
lateral portal as being important for channel function (22) and
the DTT sensitivity of double-cysteine mutants in this region
(G63C/R274C and E59C/Q321C) (16, 22).
The electron microscopy and cysteine mutant data highlight
important changes at the interface between the subunits in the
P2X1 receptor following ATP binding. Based on these experi-
ments, we propose a model (Fig. 5B) whereby agonist binding
leads to movement of the head region and right ﬂipper to close
the ATP-binding pocket and restricts access to the upper vesti-
bule. The counter-clockwise movement of the subunit “pulling”
on the β-strand 309–320 results in movement in the lateral ion-
conducting portals, and in the connected TM2 (that lines the
channel pore) that results in channel opening.
Methods
Methods are fully described in SI Methods. Brieﬂy, cRNAs encoding either
human P2X1 receptor WT or cysteine point mutants were expressed in
Xenopus oocytes. The accessibility of introduced cysteine residues was
assessed with an MTSEA-biotinylation assay. DTT sensitivity of ATP-evoked
currents fromWT and double-cysteine mutants was determined using a two-
electrode voltage-clamp recording. C-terminally FlagHis6-tagged P2X1
receptors stably expressed in HEK293 cells were puriﬁed using an anti-FLAG
gel column and prepared for electron microscopy. Data are plotted onto
a P2X1 receptor homology using PyMol.
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